Gamorez, Aldin R.
HRN: 23-12-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
05/31/2023
06/07/2023
IV
3ml
Bid
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes